Immediate Impact
1 from Science/Nature 50 standout
Citing Papers
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
Navigating the complexities of drug development for inflammatory bowel disease
2024 Standout
Works of Ralf Herold being referenced
The opportunity for greater patient and public involvement and engagement in drug development and regulation
2023
Can a Multistakeholder Prioritization Structure Support Regulatory Decision Making? A Review of Pediatric Oncology Strategy Forums Reflecting on Challenges and Opportunities of this Concept
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ralf Herold | 171 | 100 | 76 | 87 | 37 | 508 | |
| Stefanie M. Thomas | 131 | 104 | 34 | 119 | 37 | 526 | |
| Vérane Schwiertz | 99 | 73 | 41 | 31 | 31 | 574 | |
| Heather Norman | 65 | 150 | 45 | 91 | 21 | 545 | |
| Diana Sun | 51 | 55 | 64 | 121 | 32 | 569 | |
| B. Gourieux | 78 | 44 | 47 | 62 | 53 | 480 | |
| Keith Danahey | 191 | 75 | 55 | 97 | 27 | 571 | |
| Робинсон | 83 | 91 | 45 | 55 | 24 | 567 | |
| Peter J Gilbar | 109 | 59 | 44 | 26 | 59 | 544 | |
| Tamara P. Miller | 188 | 162 | 27 | 41 | 68 | 449 | |
| Cheyenne Williams | 127 | 65 | 15 | 57 | 33 | 466 |
All Works
Login with ORCID to disown or claim papers
Loading papers...